Adam Lipworth to Case-Control Studies
This is a "connection" page, showing publications Adam Lipworth has written about Case-Control Studies.
Connection Strength
0.126
-
Schwager Z, Mikailov A, Lipworth AD. Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid. J Am Acad Dermatol. 2019 06; 80(6):e189-e190.
Score: 0.115
-
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis. 2005 May 01; 40(9):1317-24.
Score: 0.011